Webinars from Children’s National Hospital.

X-rays showing hip dysplasia and hip impingement

CME Webinar: Hip Preservation: Treatment of the Painful Hip in Adolescents and Young Adults

In this webinar, Jeffrey B. Peck, M.D., pediatric orthopaedic surgeon at Children’s National Hospital and an assistant professor at The George Washington University School of Medicine & Health Sciences, discussed the field of hip preservation and how it can help patients who are experiencing hip pain.

Key takeaways

  • Overview of Hip Preservation: Hip preservation is a relatively new field in orthopedics, focusing on diagnosing and treating conditions that cause hip pain in adolescents and young adults, in order to improve pain and prevent degeneration and arthritis. Two of the most common conditions treated in hip preservation are hip dysplasia and hip impingement.
  • Hip Dysplasia: Hip dysplasia involves deficiencies in the acetabulum, leading to pain and potential arthritis. It can be diagnosed through X-rays and treated non-operatively with physical therapy or surgically with a periacetabular osteotomy.
  • Hip Impingement: Hip impingement occurs when abnormal bone shape around the hip joint causes pain and limited motion. It can be treated with physical therapy or hip arthroscopy.

More information

  • For more information on this webinar, as well as access to the presentation slide deck, visit our website.
  • To register for future CME opportunities or view past presentations, visit org/Webinars.
photograph of a pile of insulin pumps

CME Webinar: Delaying Type 1 Diabetes: Early Antibody Screening and Use of Teplizumab in Children

In this webinar, Shideh Majidi, M.D., M.S.C.S., director of the Childhood and Adolescent Diabetes Program at Children’s National Hospital, discussed early antibody screening and use of teplizumab in children.

Key takeaways

  • Current state of type 1 diabetes: Type 1 Diabetes (T1D) is characterized by absolute insulin deficiency due to pancreatic beta-cell destruction, often diagnosed in childhood but can occur in adults as well. It requires lifelong insulin management.
  • Increased risk and screening: Individuals with family members who have T1D are at higher risk of developing T1D, but most newly diagnosed cases have no family history. Early screening can help reduce diabetic ketoacidosis (DKA) rates and improve management.
  • Stages of type 1 diabetes: T1D is classified into three stages: Stage 1 (normal blood sugars with 2 or more autoantibodies), Stage 2 (dysglycemia with 2 or more autoantibodies), and Stage 3 (clinical T1D requiring insulin).
  • Early screening and follow-up: Screening for diabetes autoantibodies can be done through various programs and labs. Follow-up involves regular monitoring based on the number of antibodies and blood sugar levels. If patients have antibodies or abnormal blood sugars, they can be referred to the T1Delay Program at Children’s National (through an endocrine/diabetes referral).
  • Teplizumab (T-zield) treatment: T-zield is an FDA-approved treatment for delaying the onset of Stage 3 T1D in individuals aged 8 and older with Stage 2 T1D. It involves a 14-day infusion regimen and has been shown to delay insulin need by a median of 2 years.
  • Clinical implementation and support: Children’s National offers T-zield treatment through a multi-departmental effort. The program aims to improve both quality of life and clinical outcomes for patients.

More information

  • For more information on this webinar, as well as access to the presentation slide deck, visit our website.
  • To register for future CME opportunities or view past presentations, visit childrensnational.org/Webinars.
Title slide from Dr. Hershenson's webinar

CME Webinar: Pre-participation Cardiac Screening of Teenage Athletes: Goals, Challenges and Pitfalls

In this webinar, Jared Hershenson, M.D., pediatric cardiologist and medical director of Cardiac Exercise and Rehabilitation at Children’s National Hospital, discussed the importance, methods, challenges and recommendations of pre-participation cardiac screening, as well as secondary prevention and eligibility recommendations for athletes with known congenital heart disease.

Key takeaways

  • Importance of cardiac screening: Although sudden cardiac death in young athletes is rare, its impact is devastating, and screening aims to prevent such occurrences.
  • Causes of sudden cardiac death: Key causes include arrhythmia syndromes, cardiomyopathies, congenital coronary abnormalities and other undiagnosed congenital heart diseases.
  • Screening methods: Screening involves history and physical exams, with forms based on AHA and AAP guidelines, and may include ECGs and other tests, although these methods have limitations.
  • Challenges in screening: The sensitivity and specificity of pre-participation exams are low, and there is a lack of uniformity in how screenings are conducted, leading to potential false positives and negatives.
  • Debate on ECG screening: While ECG screening can improve sensitivity and specificity, it also has issues like false positives, which can lead to unnecessary anxiety and additional testing.
  • Secondary prevention: Secondary prevention focuses on having emergency action plans and AEDs in schools to manage sudden cardiac arrest effectively, reducing the risk of death and complications.
  • Eligibility recommendations: Guidelines for athletes with congenital heart disease emphasize individualized assessments to determine safe participation in sports, but there is a need to shift the focus to promoting physical activity rather than restricting given the long-term benefits of exercise and the low risk of sudden cardiac events.
  • Shared decision making: Shared decision making involves discussing the benefits and risks of sports participation with patients and their families, ensuring informed decisions about participation in physical activities.

More information

  • For more information on this webinar, as well as access to the presentation slide deck, visit our website.
  • To register for future CME opportunities or view past presentations, visit childrensnational.org/Webinars.